Tamoxifen Citrate
- Product NDC
- 51862-447
- 11-digit product format
- 518620447
- Labeler code
- 51862
- Product ID
- 51862-447_051df8b6-bb8a-45b8-ae9f-5339987b2584
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tamoxifen Citrate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Mayne Pharma Inc.
- Application
- ANDA075797
- Marketing category
- ANDA
- Marketing start
- 2016-08-03
- Marketing end
- 0000-00-00
- Substance
- TAMOXIFEN CITRATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51862-447-05 | 51862044705 | 500 TABLET, FILM COATED in 1 BOTTLE (51862-447-05) | 2016-08-03 | 0000-00-00 | No | No | Current |
| 51862-447-10 | 51862044710 | 1000 TABLET, FILM COATED in 1 BOTTLE (51862-447-10) | 2016-08-03 | 2022-07-31 | No | No | Current |
| 51862-447-18 | 51862044718 | 180 TABLET, FILM COATED in 1 BOTTLE (51862-447-18) | 2016-08-03 | 2021-05-31 | No | No | Current |
| 51862-447-60 | 51862044760 | 60 TABLET, FILM COATED in 1 BOTTLE (51862-447-60) | 2016-08-03 | 2022-07-31 | No | No | Current |